C2C12 골격근 세포에서 FAT/CD36 발현 조절에 있어 Insulin-like growth factor-I이 미치는 영향

국문 초록 (Abstract)

본 연구에서는 C2C12 근육 세포의 분화 과정에 있어 IGF-I이 지방산의 수송을 담당하는 지방산 수송체인 FAT/CD36의 mRNA 및 단백질 발현에 미치는 영향에 대해 알아보았다. 그 결과 근육세포의 분화 과정에 있어 FAT/CD36의 단백질과 mRNA 발현이 분화 시간 의존적으로 유의하게 증가하였으며, IGF-I의 처리에 의해서도 유의하게 조절되었음을 알 수 있었다. 이는 IGF-I이 골격근 세포의 성장 및 분화를 촉진하여 근육 관련 유전자들의 발현을 조절하는 기능뿐만 아니라, 골격근의 주요 에너지원으로 사용되는 지방산의 수송을 담당하는 FAT/CD36의 발현에도 영향을 미친다는 것으로 해석할 수 있겠다. 향후 IGF-I이 골격근 세포에서 FAT/CD36의 발현에 영향을 미침으로써 골격근의 지방산 흡수와 산화율을 조절하는지, 그에 따라 지방대사에 어떠한 영향을 미치는지에 대한 연구가 필요할 것이며, 이와 관련된 신호전달 체계 및 기전에 대한 연구도 진행 되어야 할 것이다.

다국어 초록 (Multilingual Abstract)

Fatty acid transporters are key mediators of skeletal muscle lipid metabolism. Several protein groups have been implicated in cellular long-chain fatty acid uptake or oxidation, including fatty acid transporter proteins (FATPs), the plasma membrane fatty acid-binding protein (FABPpm), and the fatty acid translocase (FAT/CD36). FAT/CD36 is highly expressed in skeletal muscle and known to be regulated by various factors such as exercise and hormones. Insulin-like growth factor-I (IGF-I) is a well-known regulator of skeletal muscle cells. However, it has not been studied whether there is any interaction between IGF-I and FAT/CD36 in skeletal muscle cells. In this study, the effects of IGF-I treatment on FAT/CD36 induction were examined. Differentiated C2C12 cells were treated with 20 ng/ml of IGF-I at different time points. Treatment of C2C12 cells with IGF-I resulted in increased FAT/CD36 mRNA and protein expression. After 24 and 48 hr of IGF-I treatment, FAT/CD36 mRNA increased 89% and 24% respectively. The increase of both proteins returned to the control level after 72 hr of IGF-I treatment, suggesting that the FAT/CD36 gene is regulated pretranslationally by IGF-I in skeletal muscle cells. These results suggest that IGF-I can regulate the expression of FAT/CD36 in skeletal muscle cells. In conclusion, IGF-I induces a rapid transcriptional modification of the FAT/CD36 gene in C2C12 skeletal muscle cells and has modulating effects on fatty acid uptake proteins as well as oxidative proteins.

목차 (Table of Contents)

• 서론
• 재료 및 방법
• 결과
• 고찰
• References
• 초록

참고문헌 (Reference)

• 1 Bonen, A., "Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36" 18 : 1144-1146, 2004
• 2 Clemmons, D. R, "The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity" 113 : 25-27, 2004
• 3 Berryman, D. E., "The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations" 9 : 346-356, 2013
• 4 Keizer, H. A., "Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres" 121 : 101-107, 2004
• 5 Schultz, E., "Skeletal muscle satellite cells" 123 : 213-257, 1994
• 6 Le Roith, D, "Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors" 336 : 633-640, 1997
• 7 Coen, P. M., "Role of intramyocelluar lipids in human health" 23 : 391-398, 2012
• 8 Phillips, S. M, "Resistance exercise: good for more than just grandma and grandpa’s muscles" 32 : 1198-1205, 2007
• 9 Bonen, A., "Regulation of fatty acid transport by fatty acid translocase/CD36" 63 : 245-249, 2004
• 10 Jordy, A. B., "Regulation of exercise-induced lipid metabolism in skeletal muscle" 99 : 1586-1592, 2014
• 11 Luiken, J. J., "Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters" 448 : 1-15, 2004
• 12 Moses, A. C., "Recombinant human insulin-like growth factor-I increases insulin sensitivity and improves glycemic control in type Ⅱ diabetes" 45 : 91-100, 1996
• 13 Van Nieuwenhoven, F. A., "Putative membrane fatty acid translocase and cytoplasmic fatty acid binding protein are co-expressed in rat heart and skeletal muscles" 207 : 747-752, 1995
• 14 Bonen, A., "Palmitate transport and fatty acid transporters in red and white muscles" 275 : E471-E478, 1998
• 15 Clarke, D. C., "Overexpression of memebrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism" 17 : 31-37, 2004
• 16 Brinkamann, J. F. F., "New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36" 367 : 561-570, 2002
• 17 Abumrad, N., "Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPpm" 1441 : 4-13, 1999
• 18 Glatz, J. F. C., "Membrane fatty acid transporters as regulators of lipid metabolism:implications for metabolic, disease" 90 : 367-417, 2010
• 19 Glatz, J. F. C., "Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake" 16 : 123-132, 2001
• 20 van Loon, L. J., "Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fated state" 553 : 611-625, 2003
• 21 Machida, S., "Insulin-like growth factor 1 and muscle growth: implication for satellite cell proliferation" 63 : 337-340, 2004
• 22 Coburn, C. T., "Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice" 275 : 32523-32529, 2000
• 23 Frystyk, J., "Cardiovascular disease and insulin-like factor-Ⅰ" 106 : 893-895, 2002
• 24 Falholt, K., "Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients" 5 : 27-31, 1998
• 25 Febbraio, M., "CD36:a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism" 108 : 785-791, 2001
• 26 Schneider, D. J., "Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type Ⅰ: implications for vascular disease in hyperinsulinemic states" 88 : 9959-9963, 1991
• 27 Bonen, A., "A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICARstimulated fatty acid metabolism" 292 : E1740-E1749, 2007